Washington, D.C. March 3, 2025 – Viscadia, a premier global management consulting firm renowned for empowering life sciences companies with clarity and confidence through forecasting, announced that Ramu Ramalingam has been appointed Principal, effective immediately. Mr. Ramalingam is an accomplished life sciences leader with 20+ years of deep experience across several disciplines, including R&D, commercial operations and business development. 

“We are delighted to welcome Ramu to Viscadia as Principal,” said Satish K. Kauta, Founder and CEO of Viscadia. “His proven track record in providing solutions for clients in the life sciences industry is invaluable to Viscadia as we enter the next stage of growth. At Viscadia, we are deeply invested in our clients’ success. Ramu’s expertise will ensure that we deliver custom forecasting solutions and support that meet the individual needs of each client. We look forward to the contributions he will make to our clients and our company.”

Prior to Viscadia, Mr. Ramalingam served as Vice President of Business Development at ACL Digital, where he was responsible for building commercial operations capabilities to secure new clients as well as grow existing relationships. Prior to ACL Digital, he was Vice President at Ontada, where he built strategic commercial plans to acquire new business for their real-world data solutions and Senior Vice President of US Sales at WNS Global Services. Mr. Ramalingam has also held data analytics, insights and forecasting leadership roles at Indegene and Schering Plough (now Merck). He holds a PhD in genetic engineering from Madurai Kamaraj University, an MS in Industrial Microbiology from the University of Madras, and an MBA in Finance from Rutgers University. 

Mr. Ramalingam commented, “I am thrilled to join Viscadia at such an exciting time in the company’s evolution. I look forward to developing deep relationships with existing clients, growing new business and collaborating with the talented team at Viscadia to help life sciences companies drive decision-making through best-in-class forecasting solutions.”  

Washington, D.C. February 24, 2025 – Viscadia, a premier global management consulting firm renowned for empowering life sciences companies with clarity and confidence through forecasting, announced that Jim Martin has been appointed Head of Client Development, effective immediately. Mr. Martin’s career spans 20+ years of driving growth for strategic consulting firms operating in the biopharma and MedTech industries.

“We are delighted to welcome Jim to Viscadia as Head of Client Development,” said Satish K. Kauta, Founder and CEO of Viscadia. “His proven track record of achieving new business and revenue growth coupled with his expertise in therapeutic portfolio strategy, new product planning, market research, and financial modeling will be invaluable as we enter the next phase of expansion for Viscadia. At Viscadia, we are deeply invested in our clients’ success. Jim’s breadth and depth of expertise will ensure that we are customizing Viscadia’s forecasting solutions to best serve our clients’ needs, allowing them to make strategic decisions with confidence.”

Prior to Viscadia, Mr. Martin served as Senior Vice President at Ipsos Healthcare Advisory, where he was responsible for new business growth for North America. Prior to Ipsos, Mr. Martin was Senior Director of Business Development for Putnam Associates, a Biopharma Strategic Consulting company, where he was focused on maximizing client portfolio value and informing investment decisions for disease, asset and portfolio strategy. He holds an MBA from Thunderbird School of Global Management at Arizona State University and a Bachelor of Science in Foreign Service from Georgetown University.

Mr. Martin commented, “I am delighted to join Viscadia at such an exciting time in the company’s evolution. The strategic landscape for the biopharma and MedTech ecosystem is dynamic, and it’s critical for firms in this space to have a trusted partner that can help them drive decisions through forecasting. As forecasting specialists, Viscadia offers unparalleled expertise. I look forward to developing outstanding relationships and delivering best-in-class forecasting solutions to companies in the life sciences industry.”

Washington, D.C. and Delhi, India – February 12, 2025 – Viscadia, a premier global management consulting firm renowned for empowering life sciences companies with clarity and confidence through forecasting, proudly announces its recognition as a Vault Top Consulting Firm in the Asia Pacific Region for the year 2025.

Vault, a leading authority in industry insights and intelligence, conducts surveys tailored to specific sectors, companies, and professions to provide comprehensive rankings and reviews. These reviews are essential for lateral hires and prospective graduates and leverage exclusive insider information from verified employees within the consulting industry. Vault’s annual surveys assess thousands of consulting professionals on key factors such as prestige, quality of life, and overall workplace satisfaction across diverse categories.

Viscadia has secured a prominent position as the 10th top firm on the prestigious list of leading consulting firms in the APAC region, climbing from 16^th in 2024.  Notably, the firm is ranked in the Top 10 on key categories such as firm culture, internal mobility, relationships with supervisors, compensation, satisfaction and selectivity, with each category representing a substantial increase in its ranking over 2024.

Commenting on this recognition, Satish K. Kauta, Founder & CEO of Viscadia, shared his satisfaction, affirming, “Being recognized as a Vault Top Consulting Firm in the Asia Pacific Region once again for 2025 is a testament to our core values as well as our commitment to be an employer of choice. I am delighted that Viscadia has reached Top 10 status, achieving new heights in its rankings across all categories.  This acknowledgment reinforces our commitment to providing exceptional value to our clients and our colleagues globally.”

Washington, D.C., February 17, 2025—Viscadia, a premier global forecasting firm renowned for empowering life sciences companies with clarity and confidence through forecasting, proudly announces its participation in the Intellus Worldwide 2025 Summit to be held from March 11-13 in Charlotte, NC. Viscadia is proud to be a Gold Sponsor of the conference.

On March 11, Viscadia will host a presentation from Doug Willson, Ph.D. entitled, “A Behavioral Economics Perspective on Forecasting and Demand Research” scheduled for 4:35 pm EST. Dr. Willson is a Principal with Viscadia and has 30 years of experience in forecasting and analytics in the life sciences industry.

Commenting on this presentation, Dr. Willson remarked, “Cognitive biases often influence demand research and forecast assumptions, resulting in inaccuracies. In this presentation, we will explore cognitive biases and discuss methods to identify and correct common mistakes in demand research to provide greater confidence in forecasting outcomes.”

Viscadia will also host a booth on the exhibit floor. Satish Kauta, Founder & CEO of Viscadia, commented, “We are delighted to have a strong presence at the Intellus Summit. We look forward to welcoming colleagues to the Viscadia booth to discuss how demand studies can inform forecast assumptions and drive better decision making.”

Washington, D.C., January 20, 2025 — Viscadia, a premier global forecasting firm renowned for empowering life sciences companies with clarity and confidence through forecasting, proudly announces its participation in the Pharma Market Research Conference taking place February 5-6 in Newark, New Jersey. Viscadia is a Lead Sponsor of the conference.

On February 5, Viscadia will host a presentation from Doug Willson, Ph.D. entitled, “New Tools for Modeling Timing and Order of Entry Effects” scheduled for 3:40 pm EST. Dr. Willson is a Principal with Viscadia and has 30 years of experience in forecasting and analytics for the life sciences industry.

Commenting on this presentation, Dr. Willson remarked, “Survey-based demand studies for pipeline products rarely provide good estimates of timing and order-of-entry effects. During this presentation, we will share new tools for modeling timing and order-of-entry that combine models based on secondary data with new metrics from survey-based demand research.”

Viscadia will also host a booth on the exhibit floor. Satish Kauta, Founder & CEO of Viscadia, commented, “We are delighted to have a strong presence at the conference. We look forward to welcoming colleagues to our booth to discuss how demand studies can inform forecast assumptions and drive better decision making.”

Delhi, India – November 5, 2024 – Viscadia, a global leader in forecasting solutions for the life sciences industry, announces its certification as one of India’s Great Places to Work® for the third consecutive year. This accolade reflects Viscadia’s ongoing commitment to creating an empowering, inclusive, and growth-oriented environment for its employees. Viscadia continues to expand its presence worldwide, with offices in Delhi, Switzerland, Boston, and Washington, D.C.

“At Viscadia, we believe that a strong, supportive workplace culture is key to delivering the best results for our clients,” said Satish Kauta, CEO and Founder of Viscadia. “Receiving this recognition for the third year in a row is a testament to our team’s dedication and the exceptional culture we have built together. We’re incredibly grateful to our employees for their commitment, and we will continue to invest in creating an environment where Viscadians can grow, collaborate, and succeed.”

Viscadia’s ethos of shared success between their team and clients has been instrumental in its growth and success over the past fourteen years. As a leader in life sciences forecasting, Viscadia’s global teams drive innovation, helping some of the world’s largest life sciences companies make informed, data-driven decisions. The company provides professional development programs, promotes a culture of continuous improvement, gives back meaningfully to the communities where they are located and encourages open communication across the organization.

Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.  The methodology used by Great Place To Work® relies primarily on employee feedback and is supplemented by organizational feedback.

 

Washington, D.C. – October 1, 2024 – Viscadia, a global consulting firm specializing in forecasting and market research for the life sciences industry, is pleased to announce its expansion with the opening of a new office in Lucerne, Switzerland. This move marks a significant milestone in Viscadia’s growth and underscores its commitment to providing world-class forecasting solutions to life sciences companies across major markets. 

Washington, D.C., April 5, 2024—Viscadia, a global consulting firm renowned for empowering life sciences companies with clarity and confidence through forecasting, proudly announces its participation in the Pharmaceutical Management Science Association Conference taking place in Denver, CO from May 5-8. Viscadia is a Gold Sponsor of the conference.

On May 6, a poster entitled, “Risk Modeling in Early-Stage Forecasts – A Machine Learning Approach” will be on display during the Welcome Reception and will be available for viewing throughout the conference. The poster was developed by Anindya Roy, a Principal with Viscadia. Anindya has 15 years of experience in forecasting and analytics for the life sciences industry.

Commenting on this poster presentation, Anindya remarked, “Understanding risks and the range of potential outcomes is crucial for decision-making predicated on early-stage forecasts. The primary source of uncertainty in these forecasts is clinical uncertainty. Risk varies significantly by therapeutic categories, and the risk landscape at the product levels has also changed significantly over time. A novel, machine learning based approach that incorporates clinical risk objectively into these early-stage forecasts will go a long way towards making them more effective and actionable”.

Viscadia will also host a booth (Booth 106-108) on the exhibit floor. Satish Kauta, Founder & CEO of Viscadia, commented, “We are delighted to have a strong presence at the conference as we enter the next phase of growth for Viscadia. We look forward to welcoming colleagues to our booth and engaging stakeholders in the life sciences forecasting ecosystem”.

Viscadia is also a co-sponsor of the Women in Analytics Luncheon on Tuesday, May 7. The company looks forward to celebrating women who are forecasting specialists and invites all who are interested in a career in forecasting to attend the luncheon and connect with the Viscadia team.

Washington, D.C., March 19, 2024—Viscadia, a premier global forecasting firm renowned for empowering life sciences companies with clarity and confidence through forecasting, proudly announces its participation in the Pharma Market Research Conference taking place in Munich, Germany from April 16-17. Viscadia is a Gold Sponsor of the conference.

On April 16, Viscadia will host a presentation from Doug Willson, Ph.D. entitled, “When You Can’t See the Forest for the Trees – Demand Research and Forecasting in Markets with Crowded Pipelines” scheduled for 12:10 pm CET. Dr. Willson is a Principal with Viscadia and has 30 years of experience in forecasting and analytics for the life sciences industry.

Commenting on this presentation, Dr. Willson remarked, “Today’s life sciences markets are increasingly competitive, and pipelines in many therapeutic areas are crowded with new products. In these complex environments it is critical now more than ever to have robust demand assumptions driving product revenue forecasts. We will discuss the different elements of demand research and forecasting in crowded markets”.

Viscadia will also host a booth on the exhibit floor. Satish Kauta, Founder & CEO of Viscadia, commented, “We are delighted to have a strong presence at the conference as we enter the next phase of growth for Viscadia globally. We look forward to welcoming colleagues to our booth and engaging stakeholders in the European life sciences ecosystem”.